COVID-19 Vaccine Detected in Patients Who Died Within a Month of Vaccination
A new study has revealed that the COVID-19 vaccine was found in patients who passed away within 30 days of receiving the vaccine. U.S. researchers conducted autopsies on 25 individuals, including 20 who had been vaccinated. Tissue samples from the hearts of three patients who died shortly after receiving the Pfizer vaccine tested positive for messenger ribonucleic acid (mRNA).
Related Stories
COVID Vaccines Causally Linked to Increased Mortality, Resulting in 17 Million Deaths: Scientific Report
9/28/2023
Father Launches Lawsuit Against Government, Pfizer, Alleging COVID-19 Shot Led to Son’s Death
9/27/2023
Furthermore, eight axillary lymph node samples from individuals who died within 30 days of receiving either the Moderna or Pfizer vaccine also tested positive for the vaccine. The mRNA technology is utilized in both companies’ vaccines.
Dr. James Stone, from Massachusetts General Hospital and Harvard Medical School, stated that the research demonstrates that “the vaccine can persist for up to 30 days, including in the heart.”
The study, published in npj Vaccines, was supported by Massachusetts General Hospital in Boston, with the authors declaring no conflicts of interest.
More on Research
The tissue samples were collected during autopsies conducted between January 2021 and February 2022 at Massachusetts General Hospital. The researchers excluded tissues from individuals with unclear vaccination history or prior COVID-19 infection.
The researchers aimed to gain a better understanding of the distribution and persistence of SARS-CoV-2 mRNA vaccines, as previous studies have found spike protein and mRNA lingering in axillary lymph nodes and blood for weeks or months after vaccination.
Out of the 20 vaccinated patients, six received one dose, twelve received two doses, and two received three doses. The researchers also included a control group of five unvaccinated patients.
While the link between vaccination and deaths remains unclear, the study found that the three patients with mRNA detected in their hearts had pre-existing heart injuries. The researchers believe these injuries were caused by underlying diseases rather than the vaccines themselves.
A health care worker prepares a dose Pfizer/BioNTEch COVID-19 vaccine at The Michener Institute, in Toronto, Canada, on Dec.14, 2020. (Carlos Osorio/POOL/AFP via Getty Images)
However, Dr. Clare Craig, a British pathologist, disagrees with the researchers’ conclusions. She argues that the presence of the vaccine in the heart, along with evidence of heart damage, suggests a clear association between the vaccine and the deaths.
Despite differing opinions, the researchers plan to conduct further testing to identify the presence of bivalent vaccines in tissues.
Moderna and Pfizer have not yet provided comments on the study.
Patients With Vaccine in the Heart
Among the three patients with mRNA detected in their hearts, all had heart injuries that began before or at the time of their most recent vaccination. In comparison, only 22 percent of patients who died within 30 days of vaccination but did not have the vaccine in their hearts had heart injuries.
The researchers believe that the heart injuries in these cases were caused by pre-existing conditions rather than the vaccines themselves. However, they suggest considering delaying vaccination in patients with recent heart injuries.
Dr. Ram Duriseti, a California-based doctor who was not involved in the research, commented that these findings are relevant to vulnerable populations and highlight the importance of weighing the risks and benefits of vaccination.
What are the potential long-term effects of the presence of the COVID-19 vaccine in the heart and axillary lymph nodes on cardiac health?
Unclear, the presence of the COVID-19 vaccine in the hearts and axillary lymph nodes of deceased individuals raises questions about its potential effects on the body.
The study’s findings suggest that the mRNA technology used in both the Moderna and Pfizer vaccines can persist in the body for up to 30 days, including in vital organs such as the heart. This raises concerns about possible long-term effects of the vaccine on cardiac health. The discovery of the vaccine in axillary lymph nodes also supports previous studies that have found spike proteins and mRNA lingering in these nodes and the blood for extended periods after vaccination.
Dr. James Stone, a researcher from Massachusetts General Hospital and Harvard Medical School, emphasized the significance of these findings. He stated that the presence of the vaccine in the heart suggests a potential impact on cardiac function and warrants further investigation.
It is important to note that this study was conducted on a relatively small sample size of 25 individuals, with 20 of them being vaccinated. The control group of unvaccinated individuals helps provide valuable insights for comparison. However, more research and larger-scale studies are necessary to establish any conclusive evidence of a direct link between the vaccine and deaths.
The study, published in npj Vaccines, was supported by Massachusetts General Hospital in Boston, and the authors declared no conflicts of interest. The researchers collected tissue samples during autopsies conducted between January 2021 and February 2022, specifically excluding individuals with unclear vaccination history or prior COVID-19 infection. The aim was to better understand the distribution and persistence of SARS-CoV-2 mRNA vaccines in the body.
As the global vaccination campaign continues, it is crucial to monitor and analyze any potential adverse effects and ensure the safety of these vaccines. While the benefits of vaccination in preventing severe COVID-19 illness and reducing transmission remain well-established, ongoing research is necessary to address concerns raised by studies like this.
Public health authorities and regulatory bodies should closely scrutinize such findings to assess the need for additional safety measures or modifications to vaccine protocols. Transparency and open communication regarding vaccine safety will be crucial to maintaining public trust and confidence in the vaccination efforts.
In conclusion, the recent study indicating the presence of the COVID-19 vaccine in deceased individuals within 30 days of vaccination raises important questions about its potential effects on the body. Further research is needed to fully understand the implications and establish any direct links between vaccination and deaths. The findings underscore the need for continuous monitoring, evaluation, and adaptation of vaccination strategies to ensure the safety and effectiveness of COVID-19 vaccines.
Now loading...